Dermapharm Holding Future Growth
Future criteria checks 1/6
Dermapharm Holding is forecast to grow earnings and revenue by 18.1% and 4.1% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 18.6% in 3 years.
Key information
18.1%
Earnings growth rate
18.1%
EPS growth rate
Pharmaceuticals earnings growth | 21.5% |
Revenue growth rate | 4.1% |
Future return on equity | 18.6% |
Analyst coverage | Low |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,281 | 140 | 168 | 228 | 4 |
12/31/2025 | 1,221 | 130 | 156 | 214 | 5 |
12/31/2024 | 1,171 | 108 | 163 | 209 | 5 |
9/30/2024 | 1,174 | 91 | 157 | 197 | N/A |
6/30/2024 | 1,147 | 83 | 146 | 187 | N/A |
3/31/2024 | 1,129 | 57 | 137 | 179 | N/A |
12/31/2023 | 1,151 | 62 | 178 | 219 | N/A |
9/30/2023 | 1,172 | 95 | 240 | 279 | N/A |
6/30/2023 | 1,151 | 123 | 267 | 304 | N/A |
3/31/2023 | 1,128 | 146 | 287 | 323 | N/A |
12/31/2022 | 1,041 | 134 | 250 | 289 | N/A |
9/30/2022 | 1,024 | 176 | 222 | 269 | N/A |
6/30/2022 | 1,004 | 185 | 191 | 249 | N/A |
3/31/2022 | 980 | 211 | 190 | 252 | N/A |
12/31/2021 | 960 | 210 | 189 | 250 | N/A |
9/30/2021 | 902 | 162 | 153 | 209 | N/A |
6/30/2021 | 858 | 123 | 115 | 164 | N/A |
3/31/2021 | 828 | 95 | 96 | 139 | N/A |
12/31/2020 | 808 | 86 | 90 | 131 | N/A |
9/30/2020 | 775 | 80 | 60 | 104 | N/A |
6/30/2020 | 760 | 77 | 58 | 97 | N/A |
3/31/2020 | 743 | 85 | 69 | 114 | N/A |
12/31/2019 | 714 | 77 | 54 | 101 | N/A |
9/30/2019 | 674 | 73 | 51 | 90 | N/A |
6/30/2019 | 639 | 77 | 70 | 109 | N/A |
3/31/2019 | 611 | 73 | 84 | 115 | N/A |
12/31/2018 | 584 | 75 | 133 | 159 | N/A |
9/30/2018 | 558 | 75 | 143 | 165 | N/A |
6/30/2018 | 525 | 76 | N/A | 137 | N/A |
3/31/2018 | 498 | 79 | N/A | 120 | N/A |
12/31/2017 | 480 | 78 | N/A | 87 | N/A |
9/30/2017 | 486 | 84 | N/A | 84 | N/A |
12/31/2016 | 455 | 77 | N/A | 77 | N/A |
12/31/2015 | 396 | 13 | N/A | 40 | N/A |
12/31/2014 | 402 | 0 | N/A | 54 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DMP's forecast earnings growth (18.1% per year) is above the savings rate (1%).
Earnings vs Market: DMP's earnings (18.1% per year) are forecast to grow slower than the German market (21.1% per year).
High Growth Earnings: DMP's earnings are forecast to grow, but not significantly.
Revenue vs Market: DMP's revenue (4.1% per year) is forecast to grow slower than the German market (5.7% per year).
High Growth Revenue: DMP's revenue (4.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DMP's Return on Equity is forecast to be low in 3 years time (18.6%).